// App-Quantinova.ai

3089 : Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.

Researchers

Presenter

  • Garth S Herbert

Principal Investigators

  • Julia M. Greene

  • John S. Berry

  • Doreen O Jackson

  • Timothy J. Vreeland

  • Diane F. Hale

  • Erica J Schneble

  • Pauline Nichol

  • Sook Yin

  • Xianzhong Yu

  • Thomas Wagner

  • George Earl Peoples

Medical Centers

  • San Antonio Military Medical Center, San Antonio, TX

  • Womack Army Medical Center, Ft. Bragg, NC

  • Perseus PCI, Greenville, SC

  • Clemson University, Clemson, SC

  • Cancer Vaccine Development Program, San Antonio, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved